Evidence map›Paper›PMID 42872013›Full record

ArticleMedical journal of the Islamic Republic of Iran2026

Genetic Characterization of Joubert Syndrome with COACH Features and in Silico Prediction of

Seyyed Saleh Hashemi, Mohammad Amir Beigi Habibabadi, Vahid Tayebi-Khorrami, Pegah Haidari, Saeed Esmaeili Dizghandi, Samaneh Zafarabadi, Shahram Salari, Mahdia Sayed, Ramin Raoufinia, Mehdi Hassani and 6 more

Abstract read
In one paragraph

Article in Medical journal of the Islamic Republic of Iran, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Seyyed Saleh HashemiDepartment of Medical Genetics and Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Mohammad Amir Beigi HabibabadiDepartment of Neurosciences, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Vahid Tayebi-KhorramiDepartment of Pharmaceutics, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
Pegah HaidariStudent Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
Saeed Esmaeili DizghandiStudent Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
Samaneh ZafarabadiStudent Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
Shahram SalariDepartment of Medical Genetics and Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Mahdia SayedStudent Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
Ramin RaoufiniaDepartment of Medical Genetics and Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Mehdi HassaniDepartment of Medical Genetics and Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Hamed AfarandeDepartment of Medical Genetics and Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Mir Salar KahaeiDepartment of Medical Genetics and Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Amin Tadayoni NiaDepartment of Medical Genetics and Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Ali ArabnezhadDepartment of Pharmacognosy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
Setayesh ZamanpourStudent Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
Karim Naghipour KojurDepartment of Medical Genetics and Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.ORCID https://orcid.org/0000-0002-8252-2018

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Joubert syndrome (JS) is an uncommon genetic condition presenting with diverse clinical manifestations involving the nervous system, liver, and eyes. A specific form of JS, known as cerebellar vermis hypoplasia, oligophrenia, ataxia, coloboma, and hepatic fibrosis (COACH) syndrome, is primarily associated with variants in the Methods: This study reports an 8-year-old girl with a family history of developmental delay who shows clinical features typical of JS with the COACH phenotype. To verify the disease-causing nature of the genetic variant, whole exome sequencing along with in silico analysis was conducted. The variant's conservation across species highlighted its functional significance, and a co-segregation study confirmed its inheritance pattern. Moreover, we collected all Results: Our investigation revealed a homozygous missense variant in Conclusion: This study highlights the intricate nature of JS and its genetic foundations, emphasizing the significance of founder variants in specific populations and the potential of national databases to enhance the precision of genetic diagnoses.

Indexed as

Iranian populationJoubert SyndromeTMEM67Whole exome sequencing

Identifiers

PMID42872013
PMCPMC13659725

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.